![]() |
|
Patent-rich companies ripe for takeover
Patent-rich ventures with healthy balance sheets and low market valuations are perfect acquisition targets for companies seeking to expand, according to exclusive research by Business XL.
Conducted in association with patent-mapping specialist CambridgeIP, Business XL has identified AIM’s 68 most IP-intensive companies, which hold more than 5,000 patents between them, and has named the largest, smallest, best-performing, most cash-rich companies on the market.
The study reveals that the ten most patent-rich companies on the market have filed more than 2,500 patents, while the ten most cash-rich intellectual property (IP) companies have £242 million on their combined balance sheets.
After Imperial Innovations, the technology transfer arm of Imperial College London, automotive technology developer Transense Technologies and fuel cell specialist IdaTech ranked second and third respectively as the most patent rich small caps on the market.
Currently valued by the market at under £7 million, Transense has 361 patented technologies on its books and therefore has one of the lowest price-per-patent ratios in the study. While US-based IdaTech is appealing but less of a bargain with at total of 357 patents and a valuation of around £48 million.
To purchase a copy of the full report, contact Calvin Green on 0207 250 7056 or calvin.green@vitessemedia.co.uk

With a MARKET VALUE OF 3.3M Transense Technologies is even more undervalued than you suggest.The market currently values the patents at around zero despite having major companies as licencee's.Realistic?
I was surprised at the number of patents quoted for Transense. They list 23 on their website - I know they lapse redundant patents so perhaps that many have been registered over the company's existence. There are a significant number of AIM companies with interesting patents but it would appear that care should be taken as numbers registered is not the same as marketable patents. In the current climate these companies deserve a serious look as they may have low cash burn and very significant upside from a bombed out price. The risk for investors is that the technology may not be endorsed or prove problematic - AFC Energy, CAP-XX, and Torotrak provide examples. Not to say that problems will not be solved or that commercialisation will not happen eventually. Of those mentioned I am biased to Transense - but then I am a shareholder, and no longer invested in the others.
Dear Taylor, the number of patents reported includes patent applications as well. When we undertook the research, we also wanted to capture indicators of the 'future' - in other words, how many patent applications are in the pipeline. You're also quite right that simple 'numbers registered' may be an insufficient measure. In some of the additional analysis we conducted (which you can find in the full report) we looked at a ranking based on the number of patent citations - and the ranking starts looking somewhat different. Yours truly, Ilian Iliev (CEO CambridgeIP)
M&A News
- Salamanca Capital buys Barcelona marina Jul 30 2010
- KBC Peel Hunt in £74 million buy-out Jul 29 2010
- Meridian Bioscience acquires Bioline Jul 28 2010
- Desmond scoops Channel Five for £104 million Jul 27 2010
- Graphite backs Teaching Personnel MBO Jul 26 2010
M&A Deals
- Aegis to acquire Mitchell Communication Group Jul 29 2010
- IDOX to buy CEMS Jul 27 2010
- MobileWave reverses onto AIM Jul 26 2010
- Fairpoint gets Moneyextra for £1 Jul 23 2010
- Synchronica to acquire iseemedia Jul 20 2010
